Medicare to Negotiate Lower Prices for Blockbuster Weight-Loss Drugs

• Medicare to negotiate drug prices, including Wegovy and Ozempic, by 2027.
• Negotiation aims to cut costs for elderly and disabled, per Inflation Reduction Act.
• Fifteen costly drugs, like Ozempic, added for Medicare price cuts.
• Medicare to expand talks to lower costs of expensive GLP-1 drugs.
• GLP-1 drugs drive high spending, impacting healthcare budgets significantly.
• Wegovy and Ozempic covered for diabetes, but not obesity, despite high costs.
• AARP predicts financial relief for Medicare enrollees from drug price negotiations.